Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis
- 31 January 1998
- journal article
- research article
- Published by Elsevier
- Vol. 81 (1) , 76-81
- https://doi.org/10.1016/s0165-5728(97)00161-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonistNature, 1997
- Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1βNature, 1997
- An interleukin 1-receptor-antagonist gene polymorphism is not associated with multiple sclerosisJournal of Neuroimmunology, 1996
- Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphismClinical and Experimental Immunology, 1995
- Different HLA-DQ are Positively and Negatively Associated in Swedish Patients with Myasthenia GravisAutoimmunity, 1995
- Myasthenia GravisNew England Journal of Medicine, 1994
- A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitroEuropean Journal of Clinical Investigation, 1992
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- Autoimmune human T lymphocytes specific for acetylcholine receptorNature, 1984
- Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.Journal of Neurology, Neurosurgery & Psychiatry, 1978